179 related articles for article (PubMed ID: 3183094)
21. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
Talpur R; Venkatarajan S; Duvic M
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
[TBL] [Abstract][Full Text] [Related]
22. Combination topical nitrogen mustard and photochemotherapy for mycosis fungoides.
Monk BE; Vollum DI; du Vivier AW
Clin Exp Dermatol; 1984 May; 9(3):243-7. PubMed ID: 6733953
[No Abstract] [Full Text] [Related]
23. Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides.
du Vivier A; Vollum DI
Br J Dermatol; 1980 Mar; 102(3):319-22. PubMed ID: 7370179
[TBL] [Abstract][Full Text] [Related]
24. Topical chemotherapy of mycosis fungoides.
Grekin DA; Zackheim HS; Epstein EH
Cutis; 1979 Nov; 24(5):543-6. PubMed ID: 520032
[TBL] [Abstract][Full Text] [Related]
25. Topical chemotherapy in mycosis fungoides.
Grupper C; Durepaire R
Bull Cancer; 1977; 64(2):323-34. PubMed ID: 912134
[No Abstract] [Full Text] [Related]
26. Electron-beam therapy for mycosis fungoides: the Stanford University experience.
Hoppe RT; Cox RS; Fuks Z; Price NM; Bagshaw MA; Farber EM
Cancer Treat Rep; 1979 Apr; 63(4):691-700. PubMed ID: 109207
[TBL] [Abstract][Full Text] [Related]
27. Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results.
Vonderheid EC; Van Scott EJ; Johnson WC; Grekin DA; Asbell SO
Arch Dermatol; 1977 Apr; 113(4):454-62. PubMed ID: 848974
[TBL] [Abstract][Full Text] [Related]
28. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.
Constantine VS; Fuks ZY; Farber EM
Arch Dermatol; 1975 Apr; 111(4):484-8. PubMed ID: 1122150
[TBL] [Abstract][Full Text] [Related]
29. [Topical chemotherapy in mycosis fungoides (author's transl)].
Touraine R; Revuz J
Dermatologica; 1978; 157(6):397-406. PubMed ID: 363476
[No Abstract] [Full Text] [Related]
30. Topical mechlorethamine therapy for mycosis fungoides. Proposed schedule to overcome drug resistance.
Volden G; Molin L; Thomsen K
Arch Dermatol; 1982 Feb; 118(2):138-9. PubMed ID: 7059219
[No Abstract] [Full Text] [Related]
31. Responses of mycosis fungoides to intensive external treatment with nitrogen mustard.
Van Scott EJ; Winters PL
Arch Dermatol; 1970 Nov; 102(5):507-14. PubMed ID: 5474113
[No Abstract] [Full Text] [Related]
32. Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides.
Delfau-Larue MH; Dalac S; Lepage E; Petrella T; Wechsler J; Farcet JP; Bagot M
Blood; 1998 Nov; 92(9):3376-80. PubMed ID: 9787176
[TBL] [Abstract][Full Text] [Related]
33. Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not?
Kalayciyan A; Oguz O; Demirkesen C; Serdaroglu S; Kotogyan A
Int J Dermatol; 2004 Dec; 43(12):953-6. PubMed ID: 15569030
[TBL] [Abstract][Full Text] [Related]
34. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.
Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT
Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308
[TBL] [Abstract][Full Text] [Related]
35. Mycosis fungoides in a lung transplant recipient with advanced ciclosporin nephropathy: management with mechlorethamine and subsequent renal transplantation.
Laffitte E; Venetz JP; Aubert JD; Duchosal MA; Panizzon RG; Pascual M
Dermatology; 2008; 217(1):87-8. PubMed ID: 18446031
[TBL] [Abstract][Full Text] [Related]
36. Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard.
Lee LA; Fritz KA; Golitz L; Fritz TJ; Weston WL
J Am Acad Dermatol; 1982 Nov; 7(5):590-8. PubMed ID: 7142467
[TBL] [Abstract][Full Text] [Related]
37. Ointment-based mechlorethamine treatment for mycosis fungoides.
Price NM; Hoppe RT; Deneau DG
Cancer; 1983 Dec; 52(12):2214-9. PubMed ID: 6640491
[TBL] [Abstract][Full Text] [Related]
38. Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides.
Vonderheid EC
Int J Dermatol; 1984 Apr; 23(3):180-6. PubMed ID: 6373639
[No Abstract] [Full Text] [Related]
39. Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
Zackheim HS; Kashani-Sabet M; Amin S
Arch Dermatol; 1998 Aug; 134(8):949-54. PubMed ID: 9722724
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous hypersensitivity and desensitization to mechlorethamine in patients with mycosis fungoides lymphoma.
Waldorf DS; Haynes HA; Van Scott EJ
Ann Intern Med; 1967 Aug; 67(2):282-90. PubMed ID: 6036390
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
